INTEGRA LIFESCIENCES HOLDINGS CORP Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) of $7.59 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2025 was $7.59M.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2024 was -$3.66M, a 200.08% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2023 was $3.66M.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2022 was -$964.00K.
| Period end | Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|
| 2025-12-31 | $7.59M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$3.66M 10-K · filed 2026-02-26 |
| 2023-12-31 | $3.66M 10-K · filed 2025-02-25 |
| 2022-12-31 | -$964.00K 10-K · filed 2024-02-28 |
| 2021-12-31 | -$1.32M 10-K · filed 2023-02-22 |
| 2020-12-31 | $3.00M 10-K · filed 2022-02-24 |
| 2019-12-31 | $406.00K 10-K · filed 2021-02-23 |
| 2018-12-31 | -$129.00K 10-K · filed 2020-02-21 |
| 2017-12-31 | -$157.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |